Stereotactic Radiosurgery

Stereotactic radiosurgery delivers a very high, precisely focused dose of radiation to a small target such as a brain tumour or vascular malformation in one to five sessions, despite its name it involves no incision. Using advanced imaging and computer-guided targeting, hundreds of narrow beams converge on the lesion from different angles so that the surrounding healthy brain tissue receives only a minimal dose. It is often used as an alternative to open surgery for tumours in locations too risky to operate on directly. Techniques include Gamma Knife, CyberKnife, and linear accelerator-based systems.

Stereotactic Radiosurgery is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Radiation Oncology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 1-5 sessions. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes Most patients go home the same day and resume light activities within a day or two. Follow-up MRI scans are performed at intervals over months to track how the treated lesion responds and shrinks over time. Steroids may be prescribed briefly to control swelling around the treated area.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Stereotactic Radiosurgery has a documented success rate of 85-95% local tumour control at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.